For payers and organizations committed to delivering the best possible care for patients while controlling costs, the pharmacy landscape has a high degree of financial risk. New drugs are approved faster than ever, even while evidence of efficacy continues to evolve.
Advanced research increasingly results in highly specialized – yet often costly – treatments for particular conditions and patient populations. Simultaneously, price doesn’t always reflect a new drug’s clinical impact, and value-oriented payment strategies continue to shift.
We can help you make sense of this complex landscape through budget impact forecasting – a comprehensive clinical and financial assessment of the drug pipeline. To produce curated and customized data-driven insights, our clinical pharmacists employ:
- Pipeline monitoring
- Evidence-based medicine review
- Market intelligence
- Pharmacy & medical claims analysis
Our independent and transparent forecasts arm you with the intelligence needed to support proactive contract negotiations and implement proactive formulary management strategies.
Refresh browser to view fully animated infographic